Report overview
Real-time PCR Molecular Diagnostics has high sensitivity, higher accuracy and less pollution, and can process test results in a timely manner, thus limiting the error range.
This report aims to provide a comprehensive presentation of the global market for PCR and Real-time PCR Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCR and Real-time PCR Molecular Diagnostics. This report contains market size and forecasts of PCR and Real-time PCR Molecular Diagnostics in global, including the following market information:
Global PCR and Real-time PCR Molecular Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global PCR and Real-time PCR Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Instruments Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of PCR and Real-time PCR Molecular Diagnostics include Abbott Laboratories, bioMereieux SA, Danaher Corporation, Bio-Rad Laboratories, QIAGEN N.V, F-Hoffmann-La Roche Ltd., Genomic Health, GRIFOLS S.A and Thermo Fisher Scientific Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PCR and Real-time PCR Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PCR and Real-time PCR Molecular Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global PCR and Real-time PCR Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
Instruments
Reagents
Consumables
Global PCR and Real-time PCR Molecular Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global PCR and Real-time PCR Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Infectious Diseases Testing
Oncology Testing
Genetic Testing
Others
Global PCR and Real-time PCR Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global PCR and Real-time PCR Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PCR and Real-time PCR Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies PCR and Real-time PCR Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
bioMereieux SA
Danaher Corporation
Bio-Rad Laboratories
QIAGEN N.V
F-Hoffmann-La Roche Ltd.
Genomic Health
GRIFOLS S.A
Thermo Fisher Scientific Inc.
Seegene Inc.
Hologic Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of PCR and Real-time PCR Molecular Diagnostics, market overview.
Chapter 2: Global PCR and Real-time PCR Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of PCR and Real-time PCR Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PCR and Real-time PCR Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
